Cargando…
Antitumor Activity of Abnormal Cannabidiol and Its Analog O-1602 in Taxol-Resistant Preclinical Models of Breast Cancer
Cannabinoids exhibit anti-inflammatory and antitumorigenic properties. Contrary to most cannabinoids present in the Cannabis plant, some, such as O-1602 and abnormal cannabidiol, have no or only little affinity to the CB(1) or CB(2) cannabinoid receptors and instead exert their effects through other...
Autores principales: | Tomko, Andrea, O’Leary, Lauren, Trask, Hilary, Achenbach, John C., Hall, Steven R., Goralski, Kerry B., Ellis, Lee D., Dupré, Denis J. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6777324/ https://www.ncbi.nlm.nih.gov/pubmed/31611800 http://dx.doi.org/10.3389/fphar.2019.01124 |
Ejemplares similares
-
Anticancer properties of cannabidiol and Δ(9)-tetrahydrocannabinol and synergistic effects with gemcitabine and cisplatin in bladder cancer cell lines
por: Whynot, Erin G., et al.
Publicado: (2023) -
Genome Assembly and Genetic Traits of the Pleuromutilin-Producer Clitopilus passeckerianus DSM1602
por: Schafhauser, Thomas, et al.
Publicado: (2022) -
Preclinical and Clinical Evidence Supporting Use of Cannabidiol in Psychiatry
por: Calapai, Gioacchino, et al.
Publicado: (2019) -
1602P COVID-19 vaccination efficacy in cancer patients: An ongoing prospective trial
por: Da Cruz Tomas, T.F., et al.
Publicado: (2021) -
Advances and Challenges of Cannabidiol as an Anti-Seizure Strategy: Preclinical Evidence
por: Zavala-Tecuapetla, Cecilia, et al.
Publicado: (2022)